VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
CTRE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CTRECareTrust REIT, Inc.
$38.77$9.2B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCTREBalance Sheet

CareTrust REIT, Inc. (CTRE) Balance Sheet

14Y historyFree accessUpdated daily

Total assets surged 156% year-over-year to $5.9B, with debt rising to $1.2B and D/E increasing to 0.27, indicating a debt-fueled expansion that warrants monitoring.

CTRE Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Total Assets5.93B5.15B3.44B2.08B1.62B1.64B1.5B1.52B1.29B1.18B925.36M673.17M482.57M430.47M398.98M
Asset Growth %186.17%49.79%64.86%28.63%-1.22%9.13%-1.01%17.58%9.01%28.06%37.46%39.5%12.1%7.89%-
Real Estate & Other Assets112.5M1.06B2.25B1.76B1.59B1.61B1.46B1.42B-1.29B-1.19B-924.47M3.18M10.4M2.8M3.92M
PP&E (Net)4.06B00000001.22B1.15B893.92M645.61M436.21M425M0
Investment Securities1000K1000K1000K00001000K1000K1000K1000K1000K1000K01000K
Total Current Assets49.27M300.6M368.26M309.85M25.89M27.15M38.42M68.34M56.85M13.06M14.77M15.89M28.42M1.8M760K
Cash & Equivalents49.27M198.04M213.82M294.45M13.18M19.89M18.92M20.33M36.79M6.91M7.5M11.47M25.32M895K735K
Receivables01000K1000K395K416K1000K1000K1000K1000K1000K1000K1000K1000K20K25K
Other Current Assets0057.26M15.01M12.29M-2.68M7.23M34.59M000000-760K
Intangible Assets048.33M4.39M5.28M2.83M1.26M2.35M1.65M2.38M2.38M1.91M0000
Total Liabilities1.43B1.09B507.63M666.12M771.41M725.09M589.42M591.27M523.51M590.37M472.93M410.88M369.11M267.78M214.43M
Total Debt1.21B894.22M396.93M595.6M719.5M673.4M545.59M554.62M489.76M558.91M449.72M393.9M358.2M259.31M207.69M
Net Debt1.16B696.18M183.1M301.15M706.32M653.5M526.67M534.3M452.97M552M442.22M382.44M332.88M258.41M206.96M
Long-Term Debt1.21B894.22M396.93M595.6M594.5M593.4M495.59M494.62M489.76M558.91M449.72M393.9M358.2M259.31M200.5M
Short-Term Borrowings0000125M80M50M60M0000007.19M
Capital Lease Obligations000000000000000
Total Current Liabilities0195.25M110.71M70.52M176.91M131.69M93.82M96.65M128.75M196.46M118.21M61.97M10.9M5.78M7.19M
Accounts Payable0120.44M56.32M33.99M24.36M25.41M19.57M14.96M15.97M17.41M12.14M9.27M6.96M5.78M0
Deferred Revenue00000000523.51M590.37M472.93M0000
Other Liabilities210.93M0000000000001.83M6.34M
Total Equity4.5B4.04B2.93B1.42B849.37M915.76M914.14M927.59M1.22B1.15B894.65M262.29M113.46M162.69M184.55M
Equity Growth %179.32%37.94%106.48%67.03%-7.25%0.18%-1.45%-24.04%6.51%28.16%241.09%131.17%-30.26%-11.84%-
Shareholders Equity4.49B4.04B2.91B1.42B849.37M915.76M914.14M927.59M768.25M594.62M452.43M262.29M113.46M162.69M184.55M
Minority Interest8.54M18.16M20.97M1.9M0000452.97M552M442.22M0000
Common Stock2.36M2.23M1.87M1.3M990K963K952K951K859K755K648K477K313K164.52M0
Additional Paid-in Capital5B4.52B3.44B1.88B1.25B1.2B1.16B1.16B965.58M783.24M611.48M410.22M246.04M00
Retained Earnings-503.2M-491.8M-532.57M-467.63M-396.95M-282.05M-251.21M-236.35M-198.19M-189.38M-159.69M-148.41M-132.89M00
Preferred Stock000000000000132.89M00
Return on Assets (ROA)6.64%7.47%4.53%2.9%-0.46%4.58%5.35%3.3%4.68%2.45%3.67%1.74%-1.78%-0.1%0.03%
Return on Equity (ROE)8.51%9.2%5.75%4.74%-0.85%7.87%8.78%4.31%4.89%2.54%5.07%5.34%-5.9%-0.23%0.06%
Debt / Assets20.32%17.37%11.55%28.57%44.39%41.04%36.29%36.52%37.91%47.17%48.6%58.52%74.23%60.24%52.06%
Debt / Equity0.27x0.22x0.14x0.42x0.85x0.74x0.60x0.60x0.40x0.49x0.50x1.50x3.16x1.59x1.13x
Net Debt / EBITDA2.26x1.68x1.01x1.80x4.58x4.09x3.40x3.90x2.47x3.81x3.47x6.54x8.21x7.17x6.14x
Book Value per Share19.2119.8018.8813.368.789.539.609.9615.3815.7815.977.024.987.318.30

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Rapid growth sustainability

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Aggressive Expansion Reshapes Balance Sheet

CTRE's total assets surged 156% year-over-year to $5.9B in 2026Q2, per latest filings, driven by a $1.2B debt-funded acquisition spree that may strain integration.

The balance sheet has expanded dramatically, with total assets growing from $2.3B in 2024Q1 to $5.9B in 2026Q2, a 156% increase. This growth was fueled by a significant rise in total debt, which jumped from $595.9M to $1.2B over the same period, indicating a leveraged acquisition strategy. While equity also grew, the pace of debt accumulation suggests the company is prioritizing growth over balance sheet conservatism, a trend investors should monitor for potential overextension.

Portfolio Quality Under Scrutiny

PP&E net is reported at $4.1B in 2026Q2, but prior quarters show zero, per financial statements, suggesting data gaps that obscure asset quality and age.

The reported PPE net of $4.1B in 2026Q2 is a stark contrast to zero in all prior quarters, which appears to be a data reporting anomaly rather than a real change. This inconsistency limits the ability to assess asset age and maintenance needs. However, the low maintenance capex of $4.4M per quarter, as noted in cash flow analysis, implies the portfolio may be relatively new or well-maintained, but the lack of consistent PPE data warrants further investigation into the actual condition of the properties.

Debt-Fueled Growth Raises Leverage

Total debt rose to $1.2B in 2026Q2, up from $396.9M a year earlier, per SEC filings, lifting D/E to 0.27 from 0.14, indicating increased financial risk.

The company's leverage has increased significantly, with total debt tripling year-over-year. The D/E ratio, while still moderate at 0.27, has nearly doubled from 0.14 in 2024Q4, reflecting the aggressive use of debt to fund acquisitions. This shift suggests a more leveraged capital structure that could amplify earnings volatility and interest rate sensitivity. Investors should monitor the maturity ladder and the proportion of fixed versus floating rate debt, as the data does not provide this breakdown.

Equity Growth Lags Debt Expansion

Equity grew to $4.5B in 2026Q2, up from $1.7B in 2024Q1, per reported figures, but debt grew faster, indicating reliance on leverage rather than retained earnings.

While equity has expanded significantly, the growth is primarily attributable to the issuance of new shares and retained earnings, but the pace of debt growth has outpaced equity growth. This suggests that the company is not solely relying on internal capital generation to fund its expansion. The FFO per share growth of 33% year-over-year, as noted in prior analysis, indicates that the equity issuance has not been overly dilutive, but the increasing leverage may pressure future returns on equity if asset yields do not exceed the cost of debt.

Liquidity Position Appears Adequate

Cash stood at $49.3M in 2026Q2, down from $223.2M in 2026Q1, per financial statements, but FFO of $119.4M provides a cushion for near-term obligations.

The cash balance has declined sharply from $223.2M to $49.3M quarter-over-quarter, likely due to acquisition activity. However, the company's FFO of $119.4M in 2026Q2, as reported, suggests that operating cash flow is strong enough to cover interest expenses and ongoing capital needs. The fixed charge coverage ratio is not directly provided, but the robust FFO and low maintenance capex imply adequate liquidity. Nevertheless, the rapid drawdown of cash reserves warrants monitoring, especially if acquisition pace continues.

Lease Expirations and Pipeline Unclear

Lease expiration schedules and development pipeline are not disclosed in the data, per available filings, limiting forward visibility on revenue stability and growth.

The provided data lacks information on lease expiration schedules, tenant concentration, and development pipeline, which are critical for assessing future revenue stability. Without this, it is difficult to gauge the risk of tenant turnover or the potential for organic growth. The rapid acquisition strategy may diversify the tenant base, but the lack of disclosure on these metrics means investors cannot fully assess the sustainability of the revenue stream. This opacity warrants further investigation into the company's portfolio composition and lease terms.

What Could Invalidate the Base Case

The 2026Q2 NOI margin of 99.8%, as reported in financial statements, appears unusually high and may indicate aggressive expense capitalization or revenue recognition practices.

The reported NOI margin of 99.8% in 2026Q2 is exceptionally high for a healthcare REIT, suggesting possible one-time items or accounting adjustments that may not be sustainable. This could indicate that the company is capitalizing expenses or recognizing revenue aggressively, which would inflate current profitability and mask underlying operational challenges. Investors should scrutinize the quality of earnings and the sustainability of such margins, as they may not reflect the true cash-generating ability of the portfolio.

CTRE — Frequently Asked Questions

Quick answers to the most common questions about buying CTRE stock.

What are the total assets of CareTrust REIT, Inc. (CTRE)?

As of 2025, CareTrust REIT, Inc. (CTRE) had total assets of $5.15B including $300.6M in current assets.

How much debt does CareTrust REIT, Inc. (CTRE) have?

CareTrust REIT, Inc. (CTRE) carries total debt of $894.2M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of CareTrust REIT, Inc.?

CareTrust REIT, Inc. (CTRE) has total shareholders' equity (book value) of $4.04B ($19.80 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is CareTrust REIT, Inc.'s current ratio and liquidity?

CareTrust REIT, Inc. (CTRE) reported a current ratio of 1.54x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.